Baker, J. G., Proudman, R. G., & Hill, S. J. (2015). Salmeterol's extreme b2 selectivity is due to residues in both extracellular loops and transmembrane domains. American Society for Pharmacology and Experimental Therapeutics.
Chicago Style (17th ed.) CitationBaker, Jillian G., Richard G.W Proudman, and Stephen J. Hill. Salmeterol's Extreme B2 Selectivity Is Due to Residues in Both Extracellular Loops and Transmembrane Domains. American Society for Pharmacology and Experimental Therapeutics, 2015.
MLA (9th ed.) CitationBaker, Jillian G., et al. Salmeterol's Extreme B2 Selectivity Is Due to Residues in Both Extracellular Loops and Transmembrane Domains. American Society for Pharmacology and Experimental Therapeutics, 2015.
Warning: These citations may not always be 100% accurate.